Investing News How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs August 24, 2022
Investing News Arrowhead Pharmaceuticals and Johnson & Johnson To Share Potentially Exciting News August 24, 2022
Investing News KalVista Hits Its Highest Point in Five Months, as Its Rival Drops Due to Hereditary Angioedema. August 22, 2022
Investing News The FDA has approved the Novavax COVID-19 vaccine for use in adolescents. August 22, 2022
Investing News Pfizer requests that the FDA approve Covid booster injections that target omicron BA.5 for individuals aged 12 and up August 22, 2022
Investing News To Increase Its Presence in Rare Hematology, Pfizer Will Purchase Global Blood Therapeutics for $5.4 Billion. August 8, 2022
Investing News Amgen Reduces Its Sales Forecast After Announcing Plans To Acquire ChemoCentryx August 5, 2022